L1-blocking antibody is now approved for metastatic or locally advanced cutaneous SCC in adults who are not candidates for curative surgery or curative radiation.
CNX Therapeutics Limited (“CNX Therapeutics”), a leading European specialty pharmaceutical company, has today announced an exclusive partnership with Adalvo to commercialise a prolonged release ...
Homeopathy was founded some two hundred years ago by Dr Samuel Christian Hahnemann. Over time, it has grown to be among the most frequently used forms of alternative medicine in Europe and the USA. It ...